#Spain #Barcelona #AMWC 2026 #Skin Tech Pharma #RRS HA Long Lasting

RRS® HA Long Lasting: A Breakthrough in Skin Revitalization

In a significant achievement for the field of aesthetic medicine, Skin Tech Pharma Group has announced that its flagship product, RRS® HA Long Lasting, has been honored as the Best Injectable in Skin Revitalization at the esteemed Aesthetic and Anti-Aging Medicine World Congress (AMWC) 2026. This awards ceremony, widely regarded as one of the most prestigious in the aesthetic sector, recognizes innovation and success in medical aesthetics, reinforcing Skin Tech's leadership in skin rejuvenation therapies.

Since its inception in 2021, RRS® HA Long Lasting has emerged as a pioneering solution in the rejuvenation sector. With over a million treatments administered globally, this injectable has established a solid reputation for its safety and clinical effectiveness. Its success can be attributed to a unique formulation that combines a hyaluronic acid-based skin builder with a blend of protective amino acids, delivering both immediate and long-term skin quality improvements.

Innovation that Redefines Aesthetic Treatments

RRS® HA Long Lasting differentiates itself from traditional fillers by offering a comprehensive approach to skin aging. Unlike mere hyaluronic fillers, it focuses on enhancing skin texture and elasticity, providing a subtle lifting effect while reducing the appearance of fine lines and wrinkles. Patients experience visible improvements right after treatment, alongside gradual enhancements over the following weeks, leading to a natural and fresh complexion.

Dr. Márcio Rodrigues, CEO of Skin Tech Pharma Group, expressed pride in receiving the award, stating, “Achieving this recognition is a milestone for us and highlights the strength of our long-term strategy. As the aesthetics landscape evolves, we are committed to leading through scientific rigor, unique innovation, and a deep understanding of healthcare professionals' needs.” He emphasized that the award not only showcases their commitment to sustainable growth but also sets the bar higher for patient care across the industry.

A Dual Action Solution for Aging Skin

RRS® HA Long Lasting operates on a dual-action platform, designed specifically to tackle the multifaceted challenges of skin aging. It stands out as the first skin revitalizer engineered to enhance both skin quality and restore natural facial volume in a single session. This innovative treatment modality is a game-changer for both practitioners and patients, streamlining processes while maximizing results.

Furthermore, clinical evidence supports its ability to improve skin texture, elasticity, and overall radiance, making it an optimal choice for individuals seeking youthfulness. Dr. Javed Hussain, a key opinion leader at Skin Tech Pharma Group, noted, “The clinical application has shown consistent improvements in the skin's texture and luminosity. This definitive skin enhancer combines a robust hyaluronic structure with a protective amino acid buffer, providing the essential components necessary to restore natural dermal function, which tends to decline with age.” He asserts that patients have reported high satisfaction levels, a testament to the product's effectiveness and reliability.

Skin Tech Pharma Group: 30 Years of Innovation

Founded in 1994 by Dr. Philippe Deprez, Skin Tech Pharma Group has solidified its position as a global leader in aesthetic medicine over the past three decades. The company is known for its high-quality medical devices and advanced cosmeceuticals, emphasizing evidence-based solutions worldwide. Their groundbreaking launch of Easy TCA® in 1996 marked the beginning of a legacy of innovation and trust in the industry.

In celebrating its 30th anniversary, Skin Tech remains committed to blending aesthetic performance with pharmaceutical rigor, thereby offering reliable and scientifically-backed solutions that meet the evolving needs of the aesthetic market. The recognition of RRS® HA Long Lasting as the Best Injectable in Skin Revitalization at AMWC 2026 is a crucial step in their journey toward setting new standards in the realm of aesthetic treatments.

For more information on RRS® HA Long Lasting and its comprehensive treatment offerings, visit Skin Tech Pharma Group’s official website.